Search clinical trials for: AML, ASLAN, DHODH
Total 16 results
-
National Human Genome Research Institute (NHGRI)RecruitingMetabolic Disease | Purine-Pyrimidine Metabolism | AICDA, OMIM *605257, Immunodeficiency With Hyper-IgM, Type 2; HIGM2 | UNG, OMIM *191525, Hyper-IgM Syndrome 5 | NT5C3A<TAB>, OMIM *606224, Anemia, Hemolytic, Due to UMPH1 Deficiency | UMPS, OMIM *613891, Orotic Aciduria | DHODH, OMIM *126064,... and other conditionsUnited States
-
ASLAN PharmaceuticalsRecruiting
-
Janssen Research & Development, LLCActive, not recruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic LeukemiaUnited Kingdom, France, Korea, Republic of, Spain
-
Kiora Pharmaceuticals, Inc.Terminated
-
Clear Creek Bio, Inc.Terminated
-
Rhizen Pharmaceuticals SAWithdrawnAcute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic Leukemia
-
Clear Creek Bio, Inc.TerminatedAcute Myeloid LeukemiaUnited States
-
Rhizen Pharmaceuticals SAIncozen Therapeutics Pvt LtdCompleted
-
Clear Creek Bio, Inc.Completed
-
PTC TherapeuticsTerminatedLeukemia, Myeloid, Acute | AMLUnited States
-
BayerTerminatedLeukemiaUnited States, France
-
Rhizen Pharmaceuticals SACompletedHealthy VolunteersUnited States
-
ASLAN PharmaceuticalsCompletedAcute Myeloid LeukemiaUnited States, Australia, Singapore
-
Novartis PharmaceuticalsCompletedAML and High Risk MDSGermany, Italy, France, Netherlands, United States, Australia, Japan
-
Agios Pharmaceuticals, Inc.Terminated
-
Changhai HospitalUnknownAcute Myeloid Leukemia | AML1-ETO Fusion Protein ExpressionChina